On Monday, 60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) opened lower -14.09% from the last session, before settling in for the closing price of $2.52. Price fluctuations for SXTP have ranged from $1.41 to $35.99 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 12.29%. Company’s average yearly earnings per share was noted 75.84% at the time writing. With a float of $1.37 million, this company’s outstanding shares have now reached $1.47 million.
Let’s determine the extent of company efficiency that accounts for 3 employees. In terms of profitability, gross margin is 40.1%, operating margin of -1570.69%, and the pretax margin is -1565.58%.
60 Degrees Pharmaceuticals Inc (SXTP) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of 60 Degrees Pharmaceuticals Inc is 6.91%, while institutional ownership is 2.04%. The most recent insider transaction that took place on Jun 03 ’25, was worth 14,410. In this transaction Director of this company bought 5,000 shares at a rate of $2.88, taking the stock ownership to the 15,816 shares. Before that another transaction happened on Dec 13 ’24, when Company’s Director bought 6,000 for $1.56, making the entire transaction worth $9,375. This insider now owns 52,078 shares in total.
60 Degrees Pharmaceuticals Inc (SXTP) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 75.84% per share during the next fiscal year.
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Trading Performance Indicators
Check out the current performance indicators for 60 Degrees Pharmaceuticals Inc (SXTP). In the past quarter, the stock posted a quick ratio of 2.71. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -31.18, a number that is poised to hit -1.24 in the next quarter and is forecasted to reach -5.36 in one year’s time.
Technical Analysis of 60 Degrees Pharmaceuticals Inc (SXTP)
Looking closely at 60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP), its last 5-days average volume was 0.73 million, which is a drop from its year-to-date volume of 1.03 million. As of the previous 9 days, the stock’s Stochastic %D was 52.00%.
During the past 100 days, 60 Degrees Pharmaceuticals Inc’s (SXTP) raw stochastic average was set at 25.08%, which indicates a significant increase from 6.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.20 in the past 14 days, which was lower than the 0.30 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.41, while its 200-day Moving Average is $3.73. However, in the short run, 60 Degrees Pharmaceuticals Inc’s stock first resistance to watch stands at $2.45. Second resistance stands at $2.73. The third major resistance level sits at $2.89. If the price goes on to break the first support level at $2.01, it is likely to go to the next support level at $1.85. Should the price break the second support level, the third support level stands at $1.56.
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Key Stats
There are currently 1,473K shares outstanding in the company with a market cap of 3.19 million. Presently, the company’s annual sales total 680 K according to its annual income of -7,950 K. Last quarter, the company’s sales amounted to 260 K and its income totaled -1,880 K.
